These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 32273039)

  • 21. From the Choice of a Regimen to the Choice of an Intensity: Changing Perspective in the Antithrombotic Therapy of Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention.
    Rubboli A; Barbaresi E; Rocca B
    Cardiovasc Drugs Ther; 2020 Feb; 34(1):143-144. PubMed ID: 31792664
    [No Abstract]   [Full Text] [Related]  

  • 22. Contemporary Antithrombotic Treatment in Patients with Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Rationale and Design of the Greek AntiPlatElet Atrial Fibrillation (GRAPE-AF) Registry.
    Xanthopoulou I; Dragona VM; Davlouros P; Tsioufis C; Iliodromitis E; Alexopoulos D;
    Cardiovasc Drugs Ther; 2018 Apr; 32(2):191-196. PubMed ID: 29679301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacotherapy for the reduction of stent thrombosis.
    Yang DC; Swaminathan RV; Kim LK; Feldman DN
    Expert Rev Cardiovasc Ther; 2013 May; 11(5):567-76. PubMed ID: 23621139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Site Variation and Outcomes for Antithrombotic Therapy in Atrial Fibrillation Patients After Percutaneous Coronary Intervention.
    Olivier CB; Fan J; Askari M; Mahaffey KW; Heidenreich PA; Perino AC; Leef GC; Ho PM; Harrington RA; Turakhia MP
    Circ Cardiovasc Interv; 2019 Aug; 12(8):e007604. PubMed ID: 31416357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antithrombotic regimens in patients with indication for long-term anticoagulation undergoing coronary interventions-systematic analysis, review of literature, and implications on management.
    Deshmukh A; Hilleman DE; Del Core M; Nair CK
    Am J Ther; 2013; 20(6):654-63. PubMed ID: 21519218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trifecta or triple threat? The challenge of post-PCI management in patients receiving chronic oral anticoagulant therapy.
    Healey JS
    Can J Cardiol; 2013 Feb; 29(2):136-8. PubMed ID: 23089529
    [No Abstract]   [Full Text] [Related]  

  • 27. Oral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery disease.
    Cairns JA; McMurtry MS
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S60-70. PubMed ID: 23790600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention: a viewpoint.
    Gwyn JCV; Thomas MR; Kirchhof P
    Eur Heart J Cardiovasc Pharmacother; 2017 Jul; 3(3):157-162. PubMed ID: 28329215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antithrombotic therapy in 2017: Advances in atherosclerosis, atrial fibrillation, and valvular disease.
    Bhatt DL
    Nat Rev Cardiol; 2018 Feb; 15(2):71-72. PubMed ID: 29297509
    [No Abstract]   [Full Text] [Related]  

  • 30. Evolving antithrombotic strategies in patients with atrial fibrillation undergoing percutaneous coronary intervention: results from a survey among US cardiologists.
    Vardi M; Debidda M; Bhatt DL; Mauri L; Cannon CP
    Clin Cardiol; 2014 Feb; 37(2):103-7. PubMed ID: 24672813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.
    Lopes RD; Rao M; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Go AS; Hylek EM; Kowey P; Piccini JP; Singer DE; Chang P; Peterson ED; Mahaffey KW
    Am J Med; 2016 Jun; 129(6):592-599.e1. PubMed ID: 26797080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triple antithrombotic therapy with aspirin, a thienopyridine derivative plus oral anticoagulation in patients with atrial fibrillation undergoing coronary stenting.
    Pipilis A; Lazaros G; Tsakonas G; Stefanadis C
    Hellenic J Cardiol; 2010; 51(4):330-7. PubMed ID: 20650831
    [No Abstract]   [Full Text] [Related]  

  • 33. Management of acute coronary syndrome in patients with non-valvular atrial fibrillation: results of the European Heart Rhythm Association Survey.
    Potpara TS; Lip GY; Dagres N; Estner HL; Larsen TB; Blomström-Lundqvist C;
    Europace; 2014 Feb; 16(2):293-8. PubMed ID: 24478291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticoagulation strategies in patients with atrial fibrillation after PCI or with ACS : The end of triple therapy?
    Fluschnik N; Becher PM; Schnabel R; Blankenberg S; Westermann D
    Herz; 2018 Feb; 43(1):20-25. PubMed ID: 29188358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual Versus Triple Antithrombotic Therapy for Atrial Fibrillation-ACS/PCI: One Size Does Not Fit All.
    Galli M; Angiolillo DJ
    Cardiovasc Revasc Med; 2022 Oct; 43():152-154. PubMed ID: 35750592
    [No Abstract]   [Full Text] [Related]  

  • 36. Meta-Analysis Comparing Dual Versus Single Antiplatelet Therapy in Combination With Antithrombotic Therapy in Patients With Atrial Fibrillation Who Underwent Percutaneous Coronary Intervention With Stent Implantation.
    Lou B; Liang X; Wu Y; Deng Y; Zhou B; Yuan Z; She J
    Am J Cardiol; 2018 Aug; 122(4):604-611. PubMed ID: 30205887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. And now we have the AUGUSTUS … How will it impact on antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention?
    Rubboli A
    Eur J Intern Med; 2019 Jul; 65():1-3. PubMed ID: 31130303
    [No Abstract]   [Full Text] [Related]  

  • 38. Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Saito Y; Kobayashi Y
    J Cardiol; 2019 Jan; 73(1):1-6. PubMed ID: 30293674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benefit of dual antithrombotic therapy with direct oral anticoagulants in patients with atrial fibrillation undergoing percutaneous coronary intervention: a systematic review and metaanalysis of randomized clinical trials.
    Zoppellaro G; Marchese GM; Squizzato A; Denas G; Patti G; De Caterina R; Pengo V
    Intern Emerg Med; 2020 Sep; 15(6):1093-1104. PubMed ID: 32617904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antithrombotic therapy after percutaneous coronary intervention from the Japanese perspective.
    Saito Y; Kobayashi Y; Tanabe K; Ikari Y
    Cardiovasc Interv Ther; 2020 Jan; 35(1):19-29. PubMed ID: 31845096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.